Evidence Synthesis
We transform complex clinical evidence into clear, decision-relevant insights to support HTA submissions and market access strategies.
- Literature Reviews – We conduct state-of-the-art systematic literature reviews (SLRs), targeted literature reviews (TLRs), and scoping reviews to comprehensively identify, evaluate, and synthesize evidence to support decision-making.
- Comparative Evidence Synthesis – Our multidisciplinary team of biostatistics experts conducts rigorous NMAs and other types of ITCs to assess the relative efficacy and safety of treatments when head-to-head evidence is limited or unavailable.
- Clinical Evidence Summaries – We translate complex clinical evidence into clear, concise, and decision-relevant summaries tailored to the requirements of Canadian HTA bodies and payers.
- Evidence Dissemination – We disseminate research findings through peer-reviewed publications, conference presentations, and other scientific communications, maximizing the impact of the evidence generated.
- Multidisciplinary Expertise – We bring together medical writing, evidence synthesis, biostatistics, and data analytics expertise to generate robust, decision-relevant evidence.
- Strategic Evidence Synthesis – We combine methodological and analytical expertise with a deep understanding of payer needs to generate evidence that supports strategic decision-making.
- Rigor you Can Rely On – We apply established methodologies and best practices to ensure the credibility, transparency, and reproducibility of our evidence synthesis.
- Proven Track-Record – With more than 200 peer-reviewed publications and conference presentations, we bring demonstrated expertise in generating and disseminating high-quality evidence.
